Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Ikushima

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
Cancer Chemotherapy and Pharmacology|July 30, 2015
A phase I/II study of fixed-dose-rate gemcitabine and S-1 with concurrent radiotherapy for locally advanced pancreatic cancerTakahiro Goji, Tetsuo Kimura, Hiroshi Miyamoto, et al.
Japanese Journal of Clinical Oncology|April 26, 2022
Large volume was associated with increased risk of acute non-hematologic adverse events in the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer: preliminary results of prospective phase I/II clinical trialNaoya Murakami, Miho Watanabe, Takashi Uno, et al.
Journal of Gynecologic Oncology|January 5, 2023
Phase I/II prospective clinical trial for the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancerNaoya Murakami, Miho Watanabe, Takashi Uno, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
Cancer Chemotherapy and Pharmacology|July 30, 2015
A phase I/II study of fixed-dose-rate gemcitabine and S-1 with concurrent radiotherapy for locally advanced pancreatic cancerTakahiro Goji, Tetsuo Kimura, Hiroshi Miyamoto, et al.
Japanese Journal of Clinical Oncology|April 26, 2022
Large volume was associated with increased risk of acute non-hematologic adverse events in the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer: preliminary results of prospective phase I/II clinical trialNaoya Murakami, Miho Watanabe, Takashi Uno, et al.
Journal of Gynecologic Oncology|January 5, 2023
Phase I/II prospective clinical trial for the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancerNaoya Murakami, Miho Watanabe, Takashi Uno, et al.
Pageof 9